Compare ALC & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALC | RJF |
|---|---|---|
| Founded | 1945 | 1962 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0B | 32.2B |
| IPO Year | N/A | N/A |
| Metric | ALC | RJF |
|---|---|---|
| Price | $78.79 | $161.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | $88.71 | ★ $181.92 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 11-11-2025 | 01-28-2026 |
| Dividend Yield | 0.27% | ★ 1.34% |
| EPS Growth | N/A | ★ 6.19 |
| EPS | 2.10 | ★ 10.30 |
| Revenue | $10,185,000,000.00 | ★ $14,015,000,000.00 |
| Revenue This Year | $5.76 | $13.69 |
| Revenue Next Year | $7.24 | $6.32 |
| P/E Ratio | $37.55 | ★ $15.59 |
| Revenue Growth | 4.34 | ★ 9.52 |
| 52 Week Low | $71.55 | $117.57 |
| 52 Week High | $99.20 | $177.66 |
| Indicator | ALC | RJF |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 46.94 |
| Support Level | $79.88 | $164.70 |
| Resistance Level | $80.88 | $166.87 |
| Average True Range (ATR) | 0.87 | 2.68 |
| MACD | -0.17 | -0.17 |
| Stochastic Oscillator | 20.34 | 13.69 |
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.